Genetic toxicology and toxicogenomic analysis of three cigarette smoke condensates in vitro reveals few differences among full-flavor, blonde, and light products by Yauk, Carole L et al.
Research Article
GeneticToxicologyandToxicogenomicAnalysis ofThree
CigaretteSmokeCondensatesInVitroRevealsFewDifferences
AmongFull-Flavor,Blonde,andLightProducts
Carole L.Yauk,* Andrew Williams, JulieK.Buick, GuoshengChen,
RebeccaM.Maertens, SabinaHalappanavar,and PaulA.White
Environmental Health Science and Research Bureau, Health Canada, Ottawa,
Ontario, Canada
Cigarette smoking leads to various detrimental
health outcomes. Tobacco companies produce dif-
ferent brands of cigarettes that are marketed as
reduced harm tobacco products. Early examples
included ‘‘light’’ cigarettes, which differ from regu-
lar cigarettes due to ﬁlter ventilation and/or differ-
ences in chemical constituents. In order to establish
baseline similarities and differences among differ-
ent tobacco brands available in Canada, the pres-
ent study examined the cytotoxicity, mutagenicity,
clastogenicity, and gene expression proﬁles of cig-
arette smoke condensate (CSC) from three tobacco
products, encompassing a full-ﬂavor, blonde, and
‘‘light’’ variety. Using the Salmonella mutagenicity
assay, we conﬁrmed that the three CSCs are muta-
genic, and that the potency is related to the pres-
ence of aromatic amines. Using the Muta
2Mouse
FE1 cell line we determined that the CSCs were
clastogenic and cytotoxic, but nonmutagenic, and
the results showed few differences in potencies
among the three brands. There were no clear
brand-speciﬁc changes in gene expression; each
brand yielded highly similar expression proﬁles
within a time point and concentration. The molecu-
lar pathways and biological functions affected by
exposure included xenobiotic metabolism, oxida-
tive stress, DNA damage response, cell cycle arrest
and apoptosis, as well as inﬂammation. Thus, there
was no appreciable difference in toxicity or gene
expression proﬁles between regular brands and
products marketed as ‘‘light,’’ and hence no evi-
dence of reduced harm. The work establishes base-
line CSC cytotoxicity, mutagenicity, and expression
proﬁles that can be used as a point of reference
for comparison with data generated for products
marketed as reduced harm and/or modiﬁed risk
tobacco products. Environ. Mol. Mutagen.
53:281–296, 2012. V V C 2012 Wiley Periodicals, Inc.
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INTRODUCTION
Cigarette smoking constitutes a major global human
health hazard. Smoking leads to a host of detrimental
health outcomes including cancer [IARC, 2004] and car-
diovascular disease [Burns, 2003]. Tobacco smoke con-
tains over 4,000 chemicals, including chemicals that are
both mutagenic and carcinogenic [reviewed in Hecht,
1999; DeMarini, 2004]. Indeed, there are over 70 known
carcinogens in mainstream tobacco smoke [Hecht, 2012].
Tobacco companies have introduced a variety of ciga-
rette products, including light cigarettes, and more
recently, cigarettes with novel ﬁlters containing activated
charcoal, which are collectively referred to as reduced
harm tobacco products. These products are marketed to
people who hope to reduce the detrimental health effects
associated with smoking. Products labeled as ‘‘light’’ cig-
arettes, a designation that has been voluntarily removed in
Canada since 2001, may have been viewed by consumers
as less addictive or toxic than full-ﬂavor varieties. Venti-
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designed to provide the impression that the smoker is
experiencing a reduction in the exposure to tobacco
smoke and its constituents. However, it has become appa-
rent that existing reduced harm tobacco products, such as
brands formerly marketed as ‘‘light,’’ present no obvious
reduction in harm compared with regular, full ﬂavor prod-
ucts [Hecht et al., 2005]. Moreover, it is now clear that
smokers compensate for increased ﬁlter ventilation in
‘‘light’’ cigarettes by modifying their pufﬁng behavior
[Rickert and Robinson, 1981; Kabat, 2003; Benowitz
et al., 2005; Hammond et al., 2005]. Modiﬁcations
include stronger pufﬁng (i.e., larger and more frequent)
that potentially results in higher nicotine, tar, and carbon
monoxide extraction. Furthermore, it has been suggested
that changes in smoking behavior (e.g., stronger puffs)
contribute to increases in carcinogen exposure (per ciga-
rette), as well as changes in the concentrations of other
smoke constituents [Thornton 1966; Schneider 1992;
Otmar and Kotzias 2007].
Commercial cigarette types vary with respect to the
chemical composition of the inhaled smoke [Chepiga
et al., 2000], with differences not only in tar and nicotine,
but also in various chemical families including: polycyclic
aromatic hydrocarbons (PAHs) [Ding et al., 2005],
tobacco-speciﬁc nitrosamines (TSNAs) [Ashley et al.,
2003], phenols [Vaughan et al., 2008], and metals [Pappas
et al., 2007; Hammond and O’Connor, 2008]. Chemical
composition of mainstream smoke is also dependent on
the various additives used, the paper type, the tobacco
processing, and other manufacturer-speciﬁc features
[Otmar and Kotzias, 2007].
In addition to differences in chemical composition, the
various tobacco brands also exhibit differences in toxicity.
For example, Bernfeld [1975] exposed female CAF1/J
mice to whole smoke, or its gas phase, and found marked
differences in the acute toxicities of whole smoke across
10 brands. Ritter et al. [2004] demonstrated statistically
signiﬁcant differences in glutathione depletion induced in a
human type II-like lung cell line following exposures to
whole smoke and ﬁltered smoke from three cigarette types.
A few studies have examined mutagenic activity across
various brands relative to a reference tobacco smoke con-
densate [Chepiga et al. 2000; Foy et al., 2004]. For exam-
ple, Foy et al. [2004], Chepiga et al. [2000] and Doolittle
et al. [1990] employed the Salmonella mutagenicity assay
to document differences in the mutagenicity of cigarette
smoke condensates (CSC) across various products, includ-
ing full ﬂavor, low tar, and ultra-low tar brands. These
studies revealed relatively small differences in the muta-
genic activity of CSCs (as revertants per unit tar or TPM)
representing the variety of products marketed in the United
States. Two previous studies have used global transcrip-
tomic analyses to establish brand-speciﬁc toxicogenomic
proﬁles [Lu et al., 2007; Pickett et al., 2010]. These
authors suggest that expression signatures can be used to
distinguish certain brands or types of cigarettes.
In the present study, we employed the Salmonella
reverse mutation assay and the in vitro LacZ transgene
mutation assay in Muta
2Mouse FE1 cells [White et al.,
2003] to evaluate the mutagenicity of CSC samples from
three cigarette brands representing three tobacco products
available in Canada. Muta
2Mouse FE1 cells were also
employed to assess cytotoxicity via clonogenic survival
and clastogenicity via the cytokinesis-block micronucleus
assay [Fenech, 2005]. In addition, a comprehensive analy-
sis of gene expression changes in FE1 cells exposed to
CSC was also conducted. The work had three primary
objectives: (1) to characterize the toxicity and mutagenicity
of three representative Canadian tobacco products; (2) to
employ gene expression proﬁling in parallel with cytotox-
icity and mutagenicity to provide a better understanding of
the mechanism of action of CSC and shed light on any dis-
tinct toxicological mechanisms underlying the in vitro
effects observed for different tobacco products; and (3) to
provide a baseline proﬁle of mutagenicity, cytotoxicity,
and gene expression changes against which new claims for
modiﬁed risk tobacco products can be evaluated.
MATERIALS ANDMETHODS
CigaretteSmokeCondensate
CSC were prepared for three popular Canadian commercial tobacco
products referred to hereafter as Brand 1, Brand 3, and Brand 5. In the
remainder of the manuscript the term ‘‘brand’’ is used to refer to a
tobacco product currently or formerly available in the Canadian market.
Brand 1 is a nonventilated Virginia ﬂue-cured product that is marketed
as a full-ﬂavor cigarette. Brand 3 contains a mixture of tobacco types
and is marketed by the manufacturer as ‘‘blonde.’’ Brand 5 contains Vir-
ginia ﬂue-cured tobacco and is marketed by the manufacturer as ‘‘light.’’
All three brands are ﬁltered cigarettes; Brands 3 and 5 contain ventilated
ﬁlters. Cigarettes were smoked and CSC samples were prepared by Lab-
stat International Inc. (Kitchener, Ontario) as previously described [Moir
et al., 2008]. Brieﬂy, each of the three cigarette brands was smoked in
triplicate using a Borgwaldt 20-port rotary smoking machine following
International Organization for Standardization (ISO) standard 3308 (i.e.,
puff volume of 35 mL, puff duration of 2 sec, puff interval of 60 sec).
The smoke was passed through a 92-mm glass ﬁber ﬁlter disk for partic-
ulate matter collection according to the Health Canada ofﬁcial test
method [Health Canada, 2004]. The number of cigarettes smoked for
each brand and the total yield of particulate matter (TPM) are provided
in Table I. To prepare condensate samples, ﬁlter pads were placed in a
ﬂask containing dimethyl sulfoxide (DMSO) (ACS spectrophotometric
grade, >99.9%) and shaken on a wrist-action shaker (model 3589, Barn-
stead International) for 20 min. Each sample was standardized to a con-
centration of 30 mg TPM per mL of DMSO.
Salmonella MutagenicityAssay
CSC samples were tested for mutagenic activity using the preincuba-
tion version of the Salmonella mutagenicity assay as described in Mor-
telmans and Zeiger [2000]. Brieﬂy, CSC were combined with the Salmo-
nella tester strain, a metabolic activation mixture derived from Aroclor
1254-induced rat liver, and incubated for 20 min at 378C. The contents
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media agar plates. Seven concentrations of each of the CSC triplicates,
ranging from 3 to 250 lg TPM per plate, were tested depending on the
potency of the sample on a given Salmonella strain (i.e., three brands,
three replicate CSC per brand, tested at seven concentrations each along-
side solvent control). Each concentration was tested in triplicate. Plates
were inverted and incubated at 378C for 72 hr. Following incubation, the
number of revertant colonies on each plate was scored using a Protocol
RGB Colony Counter (Synbiosis). Three bacterial test strains were used,
including the standard frameshift tester strain TA98, as well as two meta-
bolically enhanced versions of TA98 known as YG1041 and YG5161.
YG1041 overexpresses the Salmonella classical nitroreductase and O-ace-
tyl transferase enzymes, and shows enhanced sensitivity to nitroarenes and
aromatic amines [Hagiwara et al., 1993]. YG5161 overexpresses the dinB
gene, encoding Escherichia coli DNA polymerase IV, and shows
enhanced sensitivity to unsubstituted PAHs [Matsui et al., 2006]. Strains
YG1041 and YG5161 were obtained directly from Dr. Takehiko Nohmi
(National Institute of Health Sciences, Japan). Preliminary testing showed
a lack of response without exogenous metabolic activation (mean
responses to positive controls were 450 6 94 rev/plate 6 SD for 0.5 lg/
plate daunomycin and 736 6 67 rev/plate 6 SD for 3 lg/plate 2NF for
TA98 and YG1041, respectively). Samples were therefore tested in the
presence of a mixture containing postmitochondrial supernatant (S9)
derived from Aroclor 1254-induced rat liver. The S9 metabolic activation
mixture consisted of 2% (v/v) microsomal salt solution (0.4 M MgCl2 and
1.65 M KCl), 5 mM glucose-6-phosphate monosodium salt (Sigma-
Aldrich), 4 mM NADP disodium salt, in 0.1 M phosphate buffer pH 7.4
with 5% (v/v) Aroclor 1254-induced rat liver S9 (Moltox Inc.). Protein
levels were 35.7 to 43.5 mg/mL of rat liver S9, resulting in 0.9 to 1.1 mg
of S9 protein per plate; 2-aminoanthracene (2AA) was employed as the
positive control to ensure assay performance. All Salmonella mutagenicity
data are available from the corresponding author on request.
FE1Cell Culture
The FE1 cell line, which was derived from Muta
2Mouse lung epithe-
lium, was cultured as described in White et al. [2003]. Baseline gene
expression characteristics of cultured FE1 cells at conﬂuence and sub-
conﬂuence are described in Berndt-Weis et al. [2009]. Brieﬂy, cells were
cultured in 1:1 DMEM:F12 nutrient mixture supplemented with 2%
FBS, 2 mM glutamine, 100 U/mL penicillin G, 100 lg/mL streptomycin
sulphate, and 1 ng/mL murine epidermal growth factor (Invitrogen Life
Technologies, Canada). Incubations were conducted at 378C, 95% hu-
midity, and 5% CO2. Conﬂuence (%) was determined using replicate
plate counts. Cells on replicate plates were trypsinized and aliquots used
to assess cell number using a Coulter Particle Counter (Beckman
Coulter). This measurement was compared with a predetermined cell
count for a completely conﬂuent plate (100%). Cells from three replicate
plates at 50% conﬂuence were collected for RNA isolation.
CytotoxicityAssessment
Cytotoxicity of CSC samples was determined using a clonogenic sur-
vival assay. Brieﬂy, 2 to 3 3 10
5 FE1 cells were seeded at approxi-
mately 20% conﬂuence on 100 mm polystyrene culture plates and incu-
bated overnight. Plates were counted to determine cell density, and
duplicate plates at a known cell density were exposed, in triplicate, for 6
hr in serum-free medium to 0, 30, 60, 90, and 120 lg TPM/mL media
of each of the three CSCs. Following the exposure, cells were rinsed
with PBS, trypsin treated, removed from the plate, counted, appropriately
diluted, and plated on triplicate plates for colony formation (7–10 days).
Plates were then rinsed with PBS, colonies ﬁxed by treatment for 5 min
with 90% methanol, and stained with Giemsa (1:10 dilution of Karyo-
MAX Giemsa, Invitrogen, Canada). Cells exposed to the solvent alone
(i.e., DMSO) showed a mean colony forming efﬁciency of 19.4 6 1.4%.
Muta
2Mouse LacZ TransgeneMutationAssay
Cells were treated as described in White et al. [2003]. Brieﬂy, 2 to 3
3 10
5 FE1 cells were seeded on 100 mm polystyrene culture plates,
incubated overnight to approximately 20% conﬂuence, and exposed to a
range of CSC concentrations (10–200 lg/mL) for 6 hr in serum-free me-
dium. Since FE1 cells are known to express cytochrome p450 1A1
(Cyp1A1), and are capable of activating mutagenic carcinogens such as
benzo[a]pyrene (BaP) [White et al. 2003], initial assessment was con-
ducted in the absence of any exogenous activation mixture. Subsequent
assays employed an S9 metabolic activation mixture containing 0.5, 1, 2,
or 4% (v/v) Aroclor-induced rat liver S9. In addition, selected assays
employed preincubation of the CSC with the S9 mixture for 15, 30, or
60 min at 378C. Positive controls included 0.4 lM BaP without exoge-
nous activation and 2 lM PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-
b]pyridine) with exogenous S9 activation.
DNA isolation and scoring of transgene mutant frequency was carried
out as described [Gossen and Vijg, 1993; Vijg and Douglas, 1996; White
et al. 2003]. Brieﬂy, exposed FE1 cells were rinsed with PBS and
digested overnight in lysis buffer containing 10 mM Tris pH 7.6, 10 mM
EDTA, 10 mM NaCl, 1 mg/mL proteinase K, and 1% SDS. DNA was
isolated and puriﬁed using chloroform/phenol extraction and precipitation
in ethanol. Freshly isolated DNA was dissolved in Tris-EDTA buffer
and stored at 48C until scoring. Transgene mutant frequency was deter-
mined using the phenyl-b-D-galactopyranoside (P-gal) positive selection
assay. Brieﬂy, kgt10 lacZ DNA copies were rescued from genomic
Muta
2Mouse DNA using the Transpack
2 lambda packaging system
(Stratagene). Packaged phage particles were mixed with host bacterium
(E. coli DlacZ, galE
2, recA
2, pAA119 with galT and galK) [Gossen
and Vijg, 1993; Vijg and Douglas, 1996], plated on minimal agar with
0.3% w/v P-gal, and incubated overnight at 378C [Gossen and Vijg,
1993]. Concurrent titers on nonselective minimal agar were employed to
enumerate total plaque-forming units (pfu). Mutant frequency was
expressed as the ratio of the mutant plaques to total pfu. Preparation and
exposure of primary hepatocytes from the Muta
2Mouse was also con-
ducted as described in Chen et al. [2010].
Cytokinesis-BlockMicronucleusAssay
The frequency of spontaneous and induced micronuclei (MN) was
evaluated as described in Fenech [2005]. FE1 cells were seeded at a den-
sity of 2 3 10
5 cells/plate and grown for 24 hr at 378C in a 5% CO2
Environmental and Molecular Mutagenesis. DOI 10.1002/em
TABLE I. Number of Cigarettes Smoked and TPM Yield for each CSC. Each Condensate was Prepared in DMSO, and Stand-
ardized to a Concentration of 30 mg TPM/mL
Brand Tobacco type Filter Brand designation
a Total no. cigarettes smoked TPM yield (mg) TPM/cigarette
1 Virginia ﬂue-cured Yes, no ventilation Full-ﬂavor 60 1,625.5 27.09
3 Mixed Yes, ventilation Blonde King size 108 1,826.0 16.91
5 Virginia ﬂue-cured Yes, ventilation Light King size 117 1,659.0 14.18
aManufacturer designation. Blonde refers to a light-colored mixed tobacco that is common in US cigarettes. Full-ﬂavor brands are those that are not
marketed as light.
Toxicogenomics Analysis ofCigaretteSmokeCondensates InVitro 283atmosphere. MN frequency was evaluated for each of the three replicate
CSCs for each brand in duplicate for each dose. Cells were exposed in
serum-free media for 1 hr to 90, 120, or 150 lg/mL CSC. DMSO was
employed as the negative control (solvent blank) and mitomycin C was
used as the positive control. The treatment was removed and cells were
incubated for a further 24 hr in the presence of 3 lg/mL cytochalasin B
(Sigma-Aldrich, Canada). Cells were removed from the growth surface,
gently centrifuged, and resuspended in a 75 mM hypotonic KCl solution.
Samples were ﬁxed in 5:1 methanol:glacial acetic acid, and the cell sus-
pensions dropped onto ice-cold slides, washed with ﬁxative, and dried
overnight. Slides were stained with Giemsa for microscopic examination.
Two thousand binucleated cells were scored from each of two replicates
for each CSC triplicate.
Cell Exposures forDNA Microarrays
For microarray analysis, FE1 cells were propagated from one vial of
cryo-preserved stock of passage #19. Experiments were performed on
ﬁve replicates per condition (i.e., n 5 5 per treatment group). Cells were
exposed at 70% conﬂuence in 150 mm plates to either 45 lg/mL or 90
lg/mL CSC or 1% v/v DMSO in 1:1 DMEM:F12 (without FBS). Cells
were exposed for 6 hr and then either: (a) immediately harvested, or (b)
washed with PBS and cultured for another 4 hr in fresh media. The two
time points are referred to as 6 hr or 10 hr (i.e., 6 hr exposure with no
recovery and 6 hr exposure with 4 hr recovery). Cells were harvested
using TriZol
1 (Invitrogen Life Technologies, Canada) and stored at
2808C. Total RNA was isolated as described below.
DNA Microarrays
RNA Extraction
Total RNA was extracted from control and treated FE-1 cells in a
randomized fashion using Trizol Reagent (Invitrogen Life Technologies,
Canada) according to the manufacturer’s instructions. Subsequently, total
RNA was further puriﬁed using the RNeasy Mini Kit (Qiagen, Canada)
as directed by the manufacturer. The puriﬁed total RNA was resus-
pended in nuclease-free water. The concentration and quality of the
RNA was assessed using a NanoDrop ND-1000 spectrophotometer and
an Agilent 2100 Bioanalyzer. Sample purity was determined using the
ratio of absorbance at 260 nm and 280 nm (A260/A280) and the RNA In-
tegrity Number (RIN). All A260/A280 absorbance ratios were at least 2.0
and RINs ranged from 8.2 to 10 for all RNA samples.
DNA MicroarrayHybridization
Total RNA samples from ﬁve independent replicates from each treatment
group and time point were analyzed alongside matched solvent-exposed
controls. A reference sample (Stratagene Universal mouse reference RNA)
was hybridized to each microarray as an internal control, and for normaliza-
tion. Double-stranded cDNA and cyanine labeled cRNA were generated
according to the manufacturer’s instructions (Agilent Linear Ampliﬁcation
Kits, Agilent Technologies, Canada). Experimental samples were labeled
with cyanine 3-CTP, and reference RNA with cyanine 5-CTP (Perkin-
Elmer Life Sciences, Canada). T7 RNA polymerase was used to transcribe
cyanine-labeled cRNA targets, followed by puriﬁcation with RNeasy Mini
Kits (Qiagen, Canada). Labeled cRNA was hybridized to Agilent 22K
mouse development microarrays (  20,000 unique 60 mer oligonucleo-
tides, Agilent Technologies, Canada) at 608C overnight. Arrays were
washed and scanned on a ScanArray Express (Perkin-Elmer Life Sciences,
Canada) and data were acquired with ImaGene 5.5 (BioDiscovery Inc.).
Normalizationand StatisticalAnalysis
A reference design was used to analyze gene expression microarray
data. Background ﬂuorescence was measured using the (2)3xSLv1
probes; probes with median signal intensities less than the trimmed mean
(trim 5 5%) plus three trimmed standard deviations of the (2)3xSLv1
probes were ﬂagged and called absent. Lowess normalization was carried
out in R [R Development Core Team, 2004]. Ratio intensity plots and
heat maps for the raw and normalized data were constructed to identify
outliers. Genes that were differentially expressed as a result of treatment
were determined using two approaches. The ﬁrst approach used the
MAANOVA library in R [Wu et al., 2003]. The main effect in the
model was treatment and the model was applied to the log2 of the abso-
lute intensities. The Fs statistic was used to test for treatment effects
[Cui et al., 2005]. The P values for all statistical tests were estimated by
the permutation method using residual shufﬂing, followed by adjustment
for multiple comparisons using the false discovery rate (FDR) approach
[Benjamini and Hochberg, 1995]. The fold change calculations were
based on the least-square means. Signiﬁcant genes were identiﬁed as
having an adjusted P value <0.10 for any individual contrast.
The second microarray analysis, which was conducted independently of
the ﬁrst, used a different methodology. Fold changes were based on the
arithmetic mean of exposed versus control within groups. This estimate of
fold changes is different than that based on the least squared means
described above, which used a linear model to estimate fold change. An
ANOVA analysis was used to generate unadjusted P values. Fold changes
and P values were used to explore the gene list, looking for trends in the
data (e.g., direction and magnitude of fold changes across exposure condi-
tions). Probe replicates (i.e., multiple identical probes for the same gene)
were averaged following the statistical analysis.
Condition and gene trees were generated in GeneSpring 7.1 (Agilent
Technologies) to explore the relationships among samples using various
gene lists. Gene ontology (GO) enrichment was conducted on signiﬁcant
genes using the Database for Visualization, Annotation and Integrated
Discovery (David; available at: http://david.abcc.ncifcrf.gov [Dennis
et al., 2003; Huang da et al., 2009]). KEGG pathways were used to iden-
tify speciﬁc biological pathways associated with the differentially
expressed genes using both the signiﬁcant gene list and also a rank-based
approach on all genes [Alvo et al., 2010].
RT-qPCRValidation
RNA was extracted again for RT-qPCR and validation experiments
were conducted in accordance with the MIQE (Minimum Information
for Publication of Quantitative Real-Time PCR Experiments) guidelines
[Bustin et al., 2009].
All primers were designed using Beacon Designer 7.60 (Premier Bio-
soft International), and primer sequences are available upon request.
Temperature gradient PCR was conducted to determine the most appro-
priate Tm (8C) for each primer pair. Speciﬁc PCR ampliﬁcation efﬁcien-
cies, and correlation coefﬁcients for each gene, were determined using
ﬁve-point, 10-fold serial dilutions of pooled experimental cDNA to con-
struct the calibration curves. PCR ampliﬁcation efﬁciencies were all
between 90 and 105%, and correlation coefﬁcients were at least 0.985
for all primer pairs examined.
cDNA synthesis reactions were performed in triplicate. For each reac-
tion, 5 lg of total RNA per sample was reverse transcribed using Super-
Script
1 III Reverse Transcriptase and oligo(dT)20 primer (Invitrogen
Life Technologies, Canada) following the manufacturer’s instructions.
Real-time PCR ampliﬁcation reactions were performed in 96-well plates
using a CFX96
2 Real-Time PCR Detection System (Bio-Rad, Canada).
RT-qPCR was performed in duplicate for each cDNA sample, using iQ
2
SYBR
1 Green Supermix (Bio-Rad, Canada). A no-template control
(NTC) was included for each gene on each plate to monitor for reagent
contamination. The CFX_2StepAmp1Melt program (CFX Manager Soft-
ware, Bio-Rad, Canada) was used to validate the expression patterns of
the following 15 genes: Cdc20, Cdkn1, Cyp1b1, Egr1, Egr2, Fosl1, Il6,
Il10, Myc, Nqo1, Nr4a1, Plk1, Socs1, Socs2 and Tgfb2, and the
CFX_3StepAmp1Melt program was used to validate the expression pat-
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Prc1, and Sesn1. Speciﬁc conditions are available upon request. PCR ef-
ﬁciency was examined using the standard curve for each gene. The
threshold cycle (Ct) values for duplicate reactions were averaged.
Hypoxanthine guanine phosphoribosyl transferase 1 (Hprt1) was
selected for use as a reference gene as its expression was shown to be
stable across all experimental conditions by gene expression microarray
analysis and by RT-qPCR analysis using a subset of representative sam-
ples. Gene expression levels were normalized to the Hprt1 gene.
StatisticalData Analyses
Ordinary, least-squares linear regression of the initial linear portion of
the concentration–response functions was used to determine Salmonella
mutagenic potency values in revertants per lg TPM. For comparison
with other studies the data presented in Table II, which provide the tar
and nicotine content (mg/cig) for each brand investigated, can be used to
convert mutagenic potency values from revertants/lg TPM to revertants/
mg tar or revertants/mg nicotine. Data from Table I can be used to con-
vert potency values to revertants per cigarette. Two sample t-tests assum-
ing unequal variances, with the appropriate Bonferroni correction, were
used to contrast strain- and brand-speciﬁc mutagenic potency values.
LacZ mutation and micronucleus frequency data were analyzed by Pois-
son regression using SAS version 9.2, and the data were ﬁt to the model
log(E(Yi)) 5 log ti1b xi, where E(Yi) is the expected value for the ith
observation, b is the vector of regressions coefﬁcients, xi is a vector of
covariates for the ith observation, and ti is the offset variable used to
account for differences in observation count period (i.e., pfu or binu-
cleate cells scored). The offset (i.e., natural log of pfu or binucleate
count) was given a constant coefﬁcient of 1.0 for each observation and
log-linear relationships between mutant count or micronucleus count and
test mutagen concentration were speciﬁed by a natural log link function.
Type 1, or sequential analysis, was employed to examine the statistical
signiﬁcance of the chemical treatment, and custom contrasts were
employed to evaluate the statistical signiﬁcance of responses at selected
concentrations. Custom contrasts were accomplished by specifying an L
matrix, and computing statistics for pair wise comparisons based on the
asymptotic v
2 distribution of the likelihood ratio. The results of post hoc
pair-wise comparisons were interpreted using the Holm-Bonferroni cor-
rection for multiple comparisons.
The mathematical model used to calculate gene expression was the ef-
ﬁciency corrected calculation model [Pfafﬂ, 2006]. Gene expression vali-
dation of microarray data was conducted by calculating the relative gene
expression ratios for all 21 genes using REST08 (Relative Expression
Software Tool 2008, Corbett Research). This software allows for the
comparison of relative quantiﬁcation between treatment groups, and cal-
culates the signiﬁcance of the differences using a Pair Wise Fixed Real-
location Randomization Test [Pfafﬂ et al., 2002].
RESULTS
The numbers of cigarettes smoked to obtain the CSC
samples, and the TPM yield, both total and per cigarette,
are summarized in Table I. In addition, Table I provides in-
formation on tobacco types and the manufacturer’s brand
descriptions (i.e., light, full-ﬂavor, blonde). Table II sum-
marizes the concentrations of selected analytes in main-
stream emissions from each of the products examined.
Since tar levels in Canadian benchmark cigarettes range
from 0.7 to 15 mg/cigarette [Health Canada, 2011], the tar
values for the brands examined here indicate that all three
would be considered high tar brands. However, Brand 1 is
a high-tar Virginia ﬂue-cured brand marketed as full-ﬂavor
(i.e., not ventilated), Brand 3 is a high-tar blonde brand
containing mixed tobacco, and Brand 5 is a high-tar venti-
lated Virginia ﬂue-cured brand marketed as ‘‘light.’’ The
highest TPM yield and tar content was noted for Brand 1,
followed by Brand 3 and Brand 5, although there was little
difference between the latter two. In addition, Table II pro-
vides the IARC carcinogenicity classiﬁcation for select
analytes. The concentrations of chemical analytes in the
different CSCs are quite similar, however, some notable
differences include: (a) N-nitrosonornicotine (NNN), lead,
and isoprene were highest and cadmium lowest in Brand 3,
(b) formaldehyde and 4-(N-methylnitrosamino)-l-(3-pyri-
dyl)-l-butanone (NNK) were highest in Brand 1, and (c)
Brand 5 tended to have similar or lower levels of most ana-
lytes relative to the other brands.
Salmonella Mutagenicity
The Salmonella mutagenicity analyses showed a mean
spontaneous reversion frequency of 37.3 6 1.7, 42.9 6
2.7, and 30.5 6 1.0 rev/plate 6 SEM for TA98, YG1041,
and YG5161, respectively, in the presence of metabolic
activation. Mean response to the positive control (2AA)
was 525.8 6 51.1, 387.6 6 63.9, and 973.1 6 130.3 rev/
Environmental and Molecular Mutagenesis. DOI 10.1002/em
TABLE II. Levels of Selected Analytes, Including Several
Carcinogens, in Mainstream Emissions
a from the Cigarette
Brands Examined
Analyte
b Brand 1 Brand 3 Brand 5 Carcinogenicity
c
Tar (mg/cig) 15.6 12.9 12.4 NA
Nicotine (mg/cig) 1.3 1.1 1.1 NA
CO (mg/cig) 14.0 13.6 12.7 NA
Benzo[a]pyrene (ng/cig) 9 8 10 1
4-Aminobiphenyl (ng/cig) 2 2 2 1
3-Aminobiphenyl (ng/cig) 3 3 3 NC
2-Aminonaphthalene (ng/cig) 11 11 11 1
Pyridine (lg/cig) 19 16 11 3
NNN (ng/cig) 37 178 25 1
NNK (ng/cig) 75 63 52 1
Cadmium (ng/cig) 90 47 90 1
Lead (ng/cig) NQ 19 NQ 2B
Formaldehyde (lg/cig) 82 54 44 2A
Acetaldehyde (lg/cig) 698 680 587 2B
1,3-butadiene (lg/cig) 52 44 48 2A
Isoprene (lg/cig) 276 376 301 2B
Acrylonitrile (lg/cig) 11 12 10 2B
Benzene (lg/cig) 49 43 49 1
Styrene (lg/cig) 14 10 10 2B
aInternational Organization for Standardization (ISO) standard 3308.
Data from Controlled Substances and Tobacco Directorate, Health
Canada, 2004.
bNNN, N2-nitrosonornicotine; NNK, 4-(methylnitrosamino)-1-(3-pyri-
dyl)-1-butanone; NQ, not quantiﬁable (above the limit of detection but
below the limit of quantitation).
cAccording to IARC monographs 29, 32, 58, 71, 82, 84, 87, 88, 89, 92,
and supplements. NA indicates not applicable. NC indicates not classi-
ﬁed by IARC. 1 indicates carcinogenic to humans, 2A indicates probably
carcinogenic to humans, 2B indicates possibly carcinogenic to humans.
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YG5161 (0.5 lg/plate), respectively.
All CSC samples were mutagenic in the standard fra-
meshift test strain TA98, as well as in YG1041, which
has enhanced sensitivity to nitroarenes and aromatic
amines, and YG5161, which has enhanced sensitivity to
unsubstituted PAHs (Fig. 1). TA98 potency values were
always lowest (0.35–0.59 rev/lg TPM), followed by
YG5161 (0.51–0.73 rev/lg TPM), and YG1041 (0.80–
1.12 rev/lg TPM). For all brands investigated, mutagenic
potency values obtained for YG1041 were signiﬁcantly
greater than those for both TA98 and YG5161 (P <
0.0001). An increase in mutagenic potency on YG1041,
relative to TA98, indicates that aromatic amines are an
important determinant of CSC mutagenic activity. In addi-
tion, an increase in mutagenic potency on YG5161, rela-
tive to TA98, indicates that unsubstituted PAHs are also
determinants of CSC mutagenic activity. With respect to
the brands, Brand 3 consistently yielded the highest muta-
genic potency value. The results of the statistical compari-
sons across brands for the three Salmonella strains are
shown in Figure 1. The results show that Brand 3 is sig-
niﬁcantly more potent than Brands 1 and 5 on TA98 (P
< 0.0001 and P < 0.01), signiﬁcantly more potent than
Brand 1 on YG1041 (P < 0.0001), and signiﬁcantly more
potent than Brand 5 on YG5161 (P < 0.004). In addition,
Brand 5 was signiﬁcantly more potent than Brand 1 on
YG1041 (P < 0.006). In summary, mutagenic potency is
not markedly different across the brands, although Brand
3 elicited the highest response.
FE1Cytotoxicity
The results of the cytotoxicity analyses are illustrated
in Figure 2. The low doses of CSC (i.e., at concentrations
less than 90 lg TPM/mL) appear to be stimulatory (i.e.,
relative clonogenic survival >100%). More speciﬁcally,
at the lower concentration used for toxicogenomic analy-
ses (i.e., 45 lg TPM/mL), the CSC exposures elicited a
40 to 60% increase in clonogenic survival relative to con-
trol. Interestingly, at 30 lg TPM/mL, the peak of the
inverted U-shaped concentration–response, the CSC expo-
sures elicited 75, 67, and 48% increases in clonogenic
survival values, relative to control, for Brands 1, 3, and 5,
respectively. This type of biphasic concentration–
response, which shows an increase in survival at low con-
centrations that is generally less than twofold greater than
the control, is consistent with the compensatory response
phenomenon described by Calabrese and Baldwin [2002].
The results for Brand 1 indicate no reduction in sur-
vival at concentrations less than approximately 78 lg
TPM/mL, and Brands 3 and 5 did not elicit reduced sur-
vival at concentrations less than approximately 88 and 80
lg TPM/mL, respectively. At 90 lg TPM/mL, all brands
showed slight cytotoxicity and yielded clonogenic sur-
vival values of 85, 95, and 82% of controls for Brands 1,
3, and 5, respectively. Above 90 lg TPM/mL, all brands
showed substantial cytotoxicity, and yielded survival val-
ues that rapidly drop to below 60% of control. However,
statistical analyses showed a signiﬁcant drop in clono-
genic survival at the highest concentration, relative to the
control, only for Brands 1 and 5 (P < 0.05, one-sided t-
test). Statistical analyses failed to reveal any signiﬁcant
differences in cytotoxicity between the three brands.
FE1LacZmutagenicity
The LacZ transgene mutagenicity assay in FE1 cells
showed a mean spontaneous mutant frequency (6standard
error) of 34.3 6 3.8 and 22.8 6 0.7 3 10
25, without and
with exogenous S9 activation, respectively. The mean
response for the positive controls was 693.5 6 36.4 and 88.3
6 6.4 3 10
25 for 0.4 lMB a Pa n d2lM PhIP, respectively.
The mutagenic activity of the CSC samples on the
LacZ transgene mutagenicity assay was assessed across a
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Fig.1. Salmonella mutagenicity of CSC samples representing three ciga-
rette brands. Values shown are mean mutagenic potency values, in rever-
tants per lg TPM 6 standard error, for TA98, YG1041, and YG5161
with S9 activation. Bars accompanied by the same letter are not signiﬁ-
cantly different at P < 0.005. Employing the appropriate Bonferroni cor-
rection the critical P value is 0.0167.
Fig. 2. Cytotoxicity of CSC samples representing three cigarette brands.
The response variable indicates clonogenic survival relative to the solvent
control (i.e., 100%). Error bars represent the standard error of the mean.
286 Yauk et al.range of concentrations (10–200 lg/mL) using three
approaches: (1) in the absence of any external metabolic
activation (i.e., S9), (2) in the presence of exogenous met-
abolic activation, using an activation mixture containing
0.5, 1, 2, or 4% (v/v) rat liver S9, and (3) preincubation
of CSC samples with a rat liver metabolic activation mix-
ture for 15, 30, or 60 min at 378C before exposure of
FE1 cells. Regardless of the approach, the results failed
to detect any signiﬁcant increase in LacZ mutant fre-
quency in response to CSC exposure for any brand. Cyto-
toxicity studies conducted previously in our lab with other
CSC showed that the use of higher concentrations (160
and 200 lg TPM/mL) resulted in little to no surviving
cells. Therefore, despite the use of sufﬁciently high expo-
sure concentrations, the CSCs examined failed to induce
LacZ mutations in FE1 cells.
MicronucleusFrequency inFE1Cells
The cytokinesis-block micronucleus assay in FE1 cells
showed a mean spontaneous frequency of micronucleated
cells of 10.1 6 1.1 cells per 1,000 scored binucleates.
Exposure of FE1 cells to CSC resulted in an increase in
overall MN frequency, suggesting that all brands were capa-
ble of inducing cytogenetic damage (Fig. 3). The most
potent activity was observed for Brand 3, followed by Brand
5 and Brand 1. Brand 1 elicited the weakest response, with
only the highest tested concentration yielding a response
signiﬁcantly greater than the solvent control.
DNA Microarrays
GeneExpressionMicroarrayMAANOVA Analysis
For gene expression analysis, FE1 cells were exposed
to 45 or 90 lg TPM/mL for 6 hr. The 90 lg TPM/mL
was selected because it is the lowest concentration that
elicits a modest increase in cytogenetic damage (signiﬁ-
cantly elevated for Brand 3 only) without any signiﬁcant
increase in cytotoxicity (Figs. 2 and 3). In stark contrast,
the 45 lg/mL concentration reﬂects a concentration that
elicited a 40 to 60% increase in clonogenic survival rela-
tive to control. Selection of this concentration permitted
gene expression analysis of a concentration that does not
induce cytotoxicity or chromosome damage, and more-
over, permits a preliminary investigation of the mecha-
nism underlying the observed biphasic, compensatory
response (Fig. 2). After 6 hr of exposure, cells were either
collected into Trizol (6-hr time point), or washed and cul-
tured in fresh serum for an additional 4 hr (10-hr time
point). Analysis of MA plots and cluster analysis of the
normalized signal intensities for all probes revealed a few
outliers (i.e., unacceptable arrays, data not shown) that
were eliminated from the analyses. MAANOVA was
applied to at least four replicates in each treatment group
to identify differentially expressed genes. Genes were
considered signiﬁcant if they yielded an FDR-adjusted P
value <0.10, and a fold change greater than 1.5.
A total of 395 unique probe identiﬁers were signiﬁ-
cantly differentially expressed (i.e., up- or down-regulated
in exposed samples compared with their matched controls
at either one or both of the time points examined). Of
these, 328 genes were deemed ‘‘present’’ (full list in Sup-
porting Information Table S1). There were 47 genes that
were disregulated at the low concentration and 319 at the
high concentration; 38 genes were in common between
the two concentrations.
Overall, gene expression was most altered at the 10-hr
time point for each brand and concentration, relative to
the 6-hr time point. In total, there were 115 genes identi-
ﬁed as differentially expressed in at least one condition at
6 hr (54 down- and 61 up-regulated), and 254 at the 10-
hr time point (172 down- and 82 up-regulated). The over-
all number of differentially expressed genes was relatively
similar among the brands (Table III; Supporting Informa-
tion Table S1). Venn diagrams showing the overlap of
signiﬁcantly differentially expressed genes among brands,
within time points and concentrations, are shown in Sup-
porting Information Figure S1A–S1D, and demonstrate a
substantial overlap across the brands. The largest effect
on gene expression was found for 90 lg/mL Brand 1 at
the 10-hr time point, and the majority of the genes were
down-regulated in this condition (171 of 237). However,
in general, relatively similar numbers of genes were dif-
ferentially expressed within a concentration and time
point across the brands.
A condition tree (cluster analysis) was used to examine
the inﬂuence of brand, concentration, and time on expres-
sion proﬁles. The analysis revealed that samples clustered
ﬁrst by concentration, followed by time, with brand hav-
ing the smallest effect on the expression proﬁles. Visual
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Fig. 3. Clastogenicity of CSC samples representing three cigarette
brands. Values shown are mean numbers of micronucleated cells per
1,000 scored binucleated cells. Data were analyzed using Poisson regres-
sion, and the symbols show the results of one-way post hoc contrasts
with concurrent control, corrected using the Holm-Bonferroni method.
*Signiﬁcant increase at P < 0.05, **signiﬁcant increase at P < 0.025,
and ***signiﬁcant increase at P < 0.01.
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proﬁles were similar across the brands within a concentra-
tion and time point (Fig. 4).
The top 10 most differentially regulated genes (i.e.,
largest fold changes) were: TCDD-inducible poly(ADP-
ribose) polymerase (Tiparp; 12-fold up-regulated), B-cell
translocation gene 2, antiproliferative (Btg2; 10 fold up-
regulated), tetraspanin 33 (Tspan33; 10-fold up-regulated),
DNA-damage inducible transcript 3 (Ddit3; 10-fold up-
regulated), arrest in domain containing 3 (Arrdc3; nine-
fold up-regulated), serine (or cysteine) proteinase inhibi-
tor, clade E, member 1 (Serpine1; ninefold up-regulated),
insulin-like growth factor 1 (Igf1; eightfold up-regulated),
hemeoxygenase (decycling) 1 (Hmox1; eightfold up-regu-
lated), similar to Crb2 protein (Crb2; eightfold down-
regulated), cytochrome P450, family 1, subfamily a, poly-
peptide 1 (Cyp1a1; sevenfold up-regulated), and polo-like
kinase 1 (Drosophila) (Plk1; sevenfold down-regulated).
With the exception of Plk1, all these genes were differen-
tially regulated for all time points, concentrations, and
brands, although not always attaining FDR-adjusted statis-
tical signiﬁcance.
GO and pathway analysis of all the differentially
expressed genes revealed signiﬁcant pertubations associ-
ated with cell cycle, p53 signaling, apoptosis/programmed
cell death, and steroid/cholesterol biosynthesis (Sup-
porting Information Table S2A). Functional annotation
clustering was conducted in order to minimize redundancy
among the GO terms. This analysis revealed 23 clusters
with enrichment scores greater than 1.5 (Supporting Infor-
mation Table S3). The top cluster was associated with
cell cycle and mitosis (enrichment score 9.09; see also
clusters 8, 12 and 16, 18 for cell cycle and mitosis,
respectively), followed by cholesterol/steroid metabolic
processes (enrichment score 3.25). Other clusters relevant
to the induced DNA damage, cytotoxicity, and cell cycle-
related effects included chromosomal condensation/segre-
gation (clusters 5, 11, 13, 16, 17, 21; enrichment score
2.45), and regulation of apoptosis and cell death (both
negative and positive regulation; cluster 6, 9; enrichment
score 2.43). Thus, the analysis revealed the principal path-
ways of cell cycle, mitosis, and chromosome segregation,
as well as apoptosis and cell death.
To investigate early versus downstream effects, and to
differentiate between processes that were induced versus
repressed, GO analyses were applied to individual time
points on up-regulated versus down-regulated genes. At
the 6 hr time point, GO analysis identiﬁed 14 signiﬁcant
biological functions associated with down-regulated genes
(Supporting Information Table S2A). Twelve of these 14
were associated with cell cycle, replication, and division
including, for example, the GO terms cell cycle, mitosis,
M phase, chromosome segregation, and spindle. Analysis
of up-regulated genes at 6 hr revealed three Kegg path-
ways with Benjamini-Hochberg-adjusted P values <0.05,
and included p53 signaling, pathways in cancer, and blad-
der cancer (Supporting Information Table S2B). Twelve
GO terms were enriched among up-regulated genes and
included cell death, cellular response to stress, and tran-
scription factor activity.
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TABLE III. Total Number of Genes Up- or Down-Regulated (FDR P < 0.1 and Fold Change > 1.5) for each Brand Within
Time Point and Concentration
6H r 1 0H r
45 lg/mL 90 lg/mL 45 lg/mL 90 lg/mL
Up-regulated Down-regulated Up-regulated Down-regulated Up-regulated Down-regulated Up-regulated Down-regulated
Brand 1 5 3 22 25 24 5 68 171
Brand 3 2 0 54 30 13 11 53 47
Brand 5 4 12 37 42 8 7 82 103
Fig. 4. Heat map of the mean expression of the 328 differentially
expressed probes across the concentrations, time points and brands. Red
represents high expression relative to the reference sample, and green
represents low expression relative to reference. The cluster analysis
reveals that the expression proﬁles cluster ﬁrst by concentration,
followed by treatment.
288 Yauk et al.At 10 hr (i.e., 4 hr postexposure), down-regulated genes
were enriched for 13 GO terms, the majority of which
were again associated with cell cycle (Supporting Infor-
mation Table S2C), while the rest were related to steroid
metabolism. Down-regulated genes were enriched for sev-
eral Kegg pathways including: cell cycle, p53 signaling,
oocyte meiosis, and ubiquitin-mediated proteolysis.
DAVID analysis of up-regulated genes at 10 hr revealed
four GO terms, including terms associated with cell
death/apoptosis, and enrichment for the p53 signaling
response Kegg pathway (Supporting Information Table
S2D).
Examination of the genes that responded at the low
concentration did not reveal any signiﬁcantly enriched
functional annotation terms after adjustment for multiple
comparisons. However, pathways with nonadjusted P <
0.05 included oxidative stress response, regulation of apo-
ptosis and cell death, cell cycle, and metabolism of xeno-
biotics by cytochrome p450 (data not shown). Thus,
although fewer genes were differentially regulated at the
low concentration, the molecular pathways and functions
affected appeared to be consistent with response to the
high concentration.
GenesAssociated With CompensatoryMechanisms
Because we noted increased cell survival at the low
concentration, we examined genes that were more
affected at the low concentration relative to the high con-
centration to provide insight into the compensatory mech-
anism. Several genes showed large increases in expression
between the control and low concentration, with substan-
tially smaller increases, or decreases, relative to control,
at the high concentration. For example, genes involved in
xenobiotic metabolism and antioxidant defense, such as
Cyp1a1, Cyp1b1, and Nqo1, show two to ﬁvefold declines
in expression from low to high concentration (Table IV).
Several genes involved in cell cycle regulation, including
Cdc20, Plk1, and Prc1, also showed large (i.e., 5- to 14-
fold) declines in expression between the low and high
concentrations. These latter genes are all known to be
positive regulators of replication, cell division, and cell
proliferation [Mollinari et al., 2002; Jang et al., 2007]. In
contrast, several genes involved in p38/JNK-dependent
pathways showed continual increases in expression from
control to high concentration [Hildesheim and Fornace,
2002]. These include antiproliferative, proapoptotic, and/
or DNA damage inducible genes such as Gadd45a,
Gadd45b, Ddit3, Junb, Cdkn1a (p21), Atf3, and Fosl1.
Thus, the trends in gene expression proﬁles reﬂects a low
concentration compensatory response involving metabo-
lism, antioxidant defense, and growth stimulation, fol-
lowed by a high concentration cytotoxic response involv-
ing p38/JNK-dependent DNA repair, cell cycle arrest, and
apoptosis.
GeneExpression MicroarrayAnalysis byArithmeticMean
of Fold Changes
Previous work by various authors has suggested that
analysis of microarray data by fold change provides the
most reproducible data [Guo et al., 2006]. As such, we
also applied a more liberal approach to see whether we
could identify brand-speciﬁc effects that were not identi-
ﬁed using the stringent MAANOVA analysis. Arithmetic
means of fold changes, with unadjusted P values calcu-
lated using t-tests, and the data were ﬁltered to examine
similarities and differences across brands. We identiﬁed
approximately 1,600 probes that showed similar changes
in direction of expression consistently across all brands
and time points relative to time-matched controls (Sup-
porting Information Table S4A). These were eliminated
from our search for brand-speciﬁc effects. From the
remaining probes, genes with a fold change of at least 1.5
in any one contrast were retained for analysis of brand-
speciﬁc effects (Supporting Information Table S4B).
These genes were examined in detail to determine
whether there was any strong evidence for brand-speciﬁc
responses (e.g., up- or down-regulated in one brand only,
or differentially regulated across all but one brand within
time points, etc.). This analysis did not generate any con-
vincing examples of differences in expression proﬁles
among the CSC examined.
RT-qPCRValidation ofMicroarrayResults
A large subset of differentially expressed genes was
selected for RT-qPCR validation that spanned some of
the major pathways affected by the brands. In total, 22
genes were selected from both the MAANOVA (Sup-
porting Information Table S1) and the fold change rank
(Supporting Information Tables S4A and S4B). These
genes were selected based on involvement in the follow-
ing processes: (a) p53 signaling/DNA damage response/
cell cycle, (b) cell proliferation, differentiation, transfor-
mation, transcription factors, (c) cytokines, inﬂammatory
response, (d) xenobiotic metabolism/AhR response, (e)
antioxidant activity, and (f) steroid hormone receptor/tran-
scription factor. RT-qPCR was conducted on these genes
to conﬁrm the expression changes measured by the DNA
microarrays, in addition to searching for any clear differ-
ences among the treatment groups for these speciﬁc
genes. The results of this analysis are presented in Table
IV and reveal a remarkable consistency in response across
brands for each time and concentration. Although fold
changes tended to be larger for RT-qPCR, the data dem-
onstrate a high degree of concordance between the DNA
microarray and RT-qPCR ﬁndings, and no clear brand-
speciﬁc differences.
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The present study constitutes a comprehensive, compar-
ative study of CSCs from three tobacco products available
in Canada. The ﬁndings failed to reveal any striking dif-
ferences between the brands for any of the endpoints
examined, providing further support for the notion that
tobacco products marketed as ‘‘light’’ provide no clear
evidence of hazard reduction.
Cytotoxicityand MutagenicityoftheCSCs
The cytotoxicity and mutagenicity results presented
here support previous observations that CSC is mutagenic
and cytotoxic in both bacterial and mammalian cells
[DeMarini, 1983, 2004; Foy et al., 2004; DeMarini et al.,
2008]. Previous studies have shown that the Salmonella
mutagenic potency of CSCs is approximately 0.5 to 2.5
revertants/lg TPM [Steele et al., 1995; Chepiga et al.,
2000; Rickert et al., 2007; DeMarini et al., 2008]. This is
consistent with our results (Fig. 1) showing a range of
potencies from approximately 0.4 to 1.1 revertants/lg
TPM. The results presented here indicate that the
response was highest on the Salmonella strain YG1041,
highlighting the importance of aromatic amines in con-
tributing to the mutagenicity of CSCs derived from all
three brands. Although all brands were mutagenic, a sig-
niﬁcantly higher response was observed for Brand 3.
However, despite slight differences in mutagenicity, the
range of potencies was small. Analysis of cytotoxicity in
cultured FE1 pulmonary epithelial cells demonstrated that
the CSCs were only slightly toxic at concentrations less
than 90 lg/mL. Moreover, as noted earlier, clonogenic
survival at lower concentrations was observed to be
greater than the control. This latter result is similar to that
presented by Foy et al. [2004]. Their assessment of neu-
tral red uptake by CHO-WBL cells exposed for 24 hr to
CSCs from six different tobacco products indicate that at
10 lg/mL, cytotoxicity, expressed as percentage of con-
trol, reached as high as 117%. The difference between
this value and the low concentration compensatory
responses observed in this study (i.e., up to 178% of con-
trol) is likely due to the differential sensitivities of the
assay employed. Cytotoxicity endpoints such as neutral
red uptake, Trypan Blue exclusion, or MTT reduction
have been highlighted for their lack of sensitivity relative
to endpoints that assess replication and clonal survival
[Rossman, 2009].
Despite repeated attempts across a broad range of con-
centrations, with and without exogenous metabolic activa-
tion, we were unable to measure a signiﬁcant increase in
mutant frequency at the LacZ locus in exposed FE1 cells.
At higher concentrations, the CSCs were highly cytotoxic,
and we were unable to retrieve adequate amounts of DNA
for mutation analysis. These results are consistent with
our previous work using primary hepatocytes derived
from the Muta
2Mouse for the Brand 5 CSC at 80, 120,
and 160 lg/mL (reported elsewhere) [Chen et al., 2010].
LacZ mutant frequency in exposed primary hepatocytes
showed a small but statistically signiﬁcant increase (1.6-
fold, P < 0.005) for the low concentration only. At higher
concentrations, the primary hepatocytes showed reduced
cell survival and a low yield of extractable DNA. Guo
et al. [2011] also observed high cytotoxicity of CSCs in
mammalian cells employed for mutagenicity analyses. In
an analysis of 11 CSCs, these authors found that all
brands exhibited relatively similar mutagenic potencies
for the Tk mutation assay in mouse lymphoma cells
(L5178Y), suggesting that CSCs can induce mutations in
mammalian cells exposed in vitro. However, they also
noted that the CSCs are active across a narrow concentra-
tion range due to their high cytotoxicity. Other studies
that examined induction of mutations in mammalian cells
(e.g., the endogenous hprt locus) exposed to CSCs have
yielded mixed results. Krause et al. [1999] found a signif-
icant increase in mutations in MCL-5 cells, which carries
two recombinant plasmids expressing xenobiotic metabo-
lizing enzymes, following exposure to CSC. However,
Doolittle et al. [1990] failed to detect induced hprt muta-
tions in CHO cells exposed to CSCs both with and with-
out metabolic activation. Jongen et al. [1985] noted sig-
niﬁcant induction of hprt mutations in V79 cells exposed
to CSC, but only in the presence of exogenous metabolic
activation. Thus, the data presented here for FE1 cells,
combined with the aforementioned observations of Chen
et al. for primary hepatocytes from Muta
2Mouse, and the
mixed results presented in the literature, indicates that
CSC can induce gene mutations in mammalian cells.
However, successful detection of mutation induction
occurs over a narrow concentration range in systems that
have the appropriate metabolic capacity. To date, the
exact biochemical nature of this metabolic requirement
has not been well deﬁned.
Our results indicate that MN formation can be induced
in the FE1 cell line following exposure to CSCs. The
clastogenic potencies were 0.0076, 0.017, and 0.013
micronucleated cells/lg CSC for Brands 1, 3, and 5,
respectively. These results are consistent with published
in vitro exposures to whole cigarette smoke [Massey
et al., 1998] and CSC [Channarayappa et al., 1992; Gu
et al., 1992; DeMarini et al., 2008] that consistently show
induction of chromosome damage in the form of MN.
DeMarini et al. [2008] examined CSCs from 10 cigarette
brands and noted that all samples induced MN in mouse
lymphoma cells with a less than a 3-fold range in potency
(expressed as MN per lg CSC). The values presented
here are similar to those published by DeMarini et al.,
and, with a 2.2-fold range in potency across the brands,
supports the notion that brand-speciﬁc clastogenic potency
values do not show substantial variability. Lou et al.
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292 Yauk et al.[2010] recently assessed cytotoxicity, apoptosis, DNA
strand breaks, and MN formation in cultured human b-
lymphoblastoid cells exposed to CSCs from 12 brands.
Their results revealed induction of cytotoxicity and apo-
ptosis for all 12 CSCs. Eleven caused strand breaks in a
concentration-dependent fashion as measured by the
comet assay, and nine brands were positive in the MN
assay. Moreover, these authors noted a high degree of
correlation among the potency rankings for the assays. In
addition, the range of potency values was consistent
across the assays, except for the comet assay, which dem-
onstrated higher variability.
GeneExpression Profiling
Global gene expression signatures were investigated to
examine whether brand-speciﬁc signatures could be iden-
tiﬁed using a toxicogenomics approach, to establish base-
line gene expression proﬁles for the brands examined, and
to provide insight into the mechanisms underlying the
responses to CSC. The expression proﬁles revealed altera-
tions in genes associated with cell cycle/DNA replication
(primarily down-regulated at the higher concentration). In
keeping with the known mechanism of action of various
chemical toxicants in CSC, including PAHs and nitros-
amines, we noted up-regulation of genes involved in
xenobiotic metabolism, oxidative stress response and
DNA damage response. Although the response was great-
est at the high concentration (i.e., more genes and larger
changes), the responsive biological processes were similar
between the high and low concentrations. Nevertheless, it
is important to note that concentration-response trends for
several genes were observed, and this pattern, as well as
the aforementioned overall gene expression pattern, is
consistent with the cytotoxicity and mutagenicity results.
The concentration-related changes in gene expression
revealed that a subset of genes, including some involved
in xenobiotic metabolism and antioxidant defense, replica-
tion, cell division, and cell proliferation, show marked
decreases in expression between the low and high concen-
trations. Detailed examination of these changes indicates
that the observed trends are consistent with the compensa-
tory cytotoxicity response observed at the low concentra-
tion (i.e., increased clonal survival at the low concentra-
tion relative to the unexposed control). In contrast to pre-
vious publications [Lu et al., 2007; Pickett et al., 2010],
gene expression proﬁles were highly similar across the
three brands. Although certain brands yielded slightly
more differentially expressed genes, the trend, in both
direction and magnitude, of the fold changes were similar
across all brands. Thus, CSCs from all three brands,
including the brand marketed as ‘‘light’’ (i.e., Brand 5),
exhibited highly similar gene expression proﬁles.
To our knowledge, two previous studies have used
global transcriptomic analyses to attempt to discern
brand-speciﬁc toxicogenomic proﬁles and identify candi-
date biomarker genes. These studies produced lists of
genes that were hypothesized to potentially be useful in
assessing exposures to certain brands or types of ciga-
rettes (e.g., varying tar-content). Pickett et al. [2010]
explored gene expression changes in cultured primary
human bronchial epithelial cells (collected from one indi-
vidual) exposed to CSCs from 10 brands of cigarettes.
Cells were exposed to CSCs for 18 hr, and exposures
were based on nicotine concentration (4 lg/mL). In con-
trast, the exposure design in our experiment was based on
CSC concentration, and nicotine concentrations were
approximately 4.3, 5.9, and 7.0 lg/mL for the high con-
centrations of Brand 1, Brand 3, and Brand 5, respectively
(1.6-fold variation in nicotine content across our study).
Thus, the nicotine exposure concentrations used in Pickett
et al. were similar to our study. Pickett et al. identiﬁed 21
genes that appeared to be differentially regulated across
most brands in the primary human bronchial cells. These
genes included Nqo1, Cyp1a1, Cyp1b1, Akr1c1/c2 (we
found Akr1c18), Angptl4, Fbxo32 (we found Fbxo5),
Gdf2 (we found Gdf9 and Gdf15), and Cxcl14, which
were also identiﬁed as differentially expressed in the cur-
rent study. Thus, approximately 40% of the genes identi-
ﬁed in the Pickett et al. study are consistent with our
work, despite being conducted in different cells from a
different species exposed for 18 hr, rather than 6 hr. Pick-
ett et al. identiﬁed genes that they proposed are unique to
the various brands by using a twofold threshold and a
Venn diagram approach. However, the analysis was lim-
ited by a lack of biological and/or technical replicates
(i.e., duplicates only), a single concentration, and a single
time point. Therefore, although the authors found some
genes that appeared to show a unique response to individ-
ual brands, these ﬁndings should be interpreted with cau-
tion as additional concentrations and time points are nec-
essary to conﬁrm the results.
Lu et al. [2007] compared cytotoxicity (neutral red
assay) and global gene expression in mouse Balb/3T3
ﬁbroblast cell cultures exposed to CSCs using an in vitro
whole smoke exposure system. Cells were exposed for 1
hr to three commercial cigarette brands (one full-ﬂavor,
one low tar, and one ultra-low tar), and one type of refer-
ence cigarette, at wet total particulate matter levels that
gave similar cytotoxicities (10–20%) and nicotine concen-
trations across the cigarette types. Samples were analyzed
5 hr after a 1 hr exposure. The authors found that cyto-
toxicity decreased with tar content, and identiﬁed a total
of 598, 176, and 234 differentially expressed genes for
the full-ﬂavor, low tar, and ultra-low tar cigarettes,
respectively. The pathways and processes perturbed in
these cells are similar to those identiﬁed here. Inﬂamma-
tory and glutathione reduction processes were up-regu-
lated and cell proliferation/replication pathways were
down-regulated. The authors found that the latter two
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response, with high tar content cigarettes having the
greatest effect on cell cycle, and using class predictions
and a set of 100 selected ‘‘predictor’’ genes, they sug-
gested that a transcriptomic analysis could be used to cor-
rectly classify exposed samples into cigarette groups.
However, this work analyzed only three brands, and it
would be necessary to verify the utility of the identiﬁed
predictor genes.
The results of the two studies described above are con-
sistent with the present study in terms of the pathways
affected by CSCs. First, there is a large overlap in the
genes, gene families, and biological processes observed in
our study in comparison with these studies. In our study,
the largest number of differentially expressed genes was
found for Brand 1 (237 genes), a full-ﬂavor cigarette con-
taining Virginia ﬂue-cured tobacco that has the highest tar
and nicotine content of the three brands examined. This is
consistent with Lu et al. [2007]. Indeed, this brand had
approximately two times as many genes meeting our sta-
tistical threshold, suggesting that it induced a more sub-
stantial overall cellular effect. Moreover, in keeping with
Lu et al., the majority of the genes perturbed by Brand 1
CSC were involved in cell cycle control. Although Brand
5 and Brand 3 (which are different tobacco blends) each
have similar levels of tar (12.4 and 12.9 mg/cig, respec-
tively) and nicotine (both have 1.1 mg/cig), Brand 5
yielded more differentially expressed genes than Brand 3
at the most active exposure condition (185 vs. 100 genes).
Although more genes were signiﬁcantly differentially
expressed following exposure to the Brand 1 CSC in our
study, the overall gene expression analysis does not sup-
port the existence of a tobacco product-speciﬁc gene
expression signature. By applying a large sample size,
multiple concentrations and two time points, we found lit-
tle evidence for CSC-speciﬁc proﬁles for the three brands
analyzed. Although there were instances where fold
changes may have been larger for certain brands (or have
lower P values), the general trends among the brands
were similar, with no concrete evidence that certain genes
were responsive in a brand-speciﬁc manner. Clustering of
all signiﬁcant genes revealed that genes were grouped ﬁrst
by concentration, then time, with brand having little inﬂu-
ence on the expression patterns. Using a more liberal
analysis based on fold changes and unadjusted P values,
and using RT-qPCR, we found that genes were highly
correlated across the brands with no obvious brand-spe-
ciﬁc effects. Thus, we did not ﬁnd evidence of brand spe-
ciﬁc signatures, despite differences in the way the brands
are marketed.
The major effect of tobacco smoke on cell cycle
observed in all studies is consistent with a p53-induced
DNA damage response and chromosome damage at ele-
vated concentrations. Indeed, disruption of cell cycle and
oxidative stress are two pathways by which clastogenicity
is thought to arise in cells exposed to CSC in vitro
[DeMarini, 2004; Guo et al., 2006, 2011; Lu et al., 2007;
DeMarini et al., 2008]. Cluster analyses on genes from
these pathways (p53 and cell cycle) demonstrate that
genes are correlated primarily by concentration, followed
by time, and ﬁnally brand, which does not exert a major
effect on gene expression, again supporting our conclu-
sion that there are no clear brand-speciﬁc effects for the
three CSCs examined in the present study.
The present work is also consistent with our earlier
ﬁndings in vivo in lung samples collected from mice
exposed for 6 or 12 weeks to mainstream tobacco smoke.
Employing the same Agilent array and analytical meth-
ods, Halappanavar et al. [2009] found differential expres-
sion of 79 genes following chronic smoke exposure. Fif-
teen of these genes were differentially regulated in the
same direction as in the present work on cultured FE1
epithelial cells, and included: Cyp1a1, Cyp1b1, Ahr,
Nqo1, Srxn1, Aldh3a1, Alk1, Gclm, Hmox1, Il6, Ptgs2,
Ier3, Pdgfrb, Klf9, and Lincr. A large number of com-
monalities in pathways and functions are also evident;
including xenobiotic metabolism, redox balance, oxidative
stress, glutathione metabolism, inﬂammatory response,
heat shock proteins, signal transduction pathways, and
transport (12 members of the solute carrier family were
differentially regulated in vitro). Thus, despite noteworthy
differences in the exposure regime (i.e., in vitro vs. in
vivo), concentration, time, exposure material (i.e., main-
stream tobacco smoke vs. CSC), we see a high degree of
functional overlap in gene expression, which implies that
the results obtained in vitro are relevant to in vivo out-
comes.
CONCLUSIONS
The present study conﬁrms that CSC is clastogenic, cy-
totoxic, and mutagenic, with little differences in potencies
across three CSCs representing three different tobacco
products. The molecular pathways and biological func-
tions affected by exposure to CSCs are consistent with
previous studies demonstrating xenobiotic metabolism,
oxidative stress, DNA damage response leading to cell
cycle arrest and apoptosis, as well as inﬂammation. More-
over, at matched CSC concentrations, the brands exam-
ined, which included both full-ﬂavor and light, and a
blonde tobacco product, exhibited highly similar toxicoge-
nomic responses and no evidence of brand-speciﬁc gene
expression proﬁles. Thus, although the study only ana-
lyzed a small number of brands, the results provide no
mechanistic support for any contention of harm reduction
for a tobacco product marketed as ‘‘light.’’ It should be
noted that we do not have quantitative information on
smoking habits for the brands examined in this study, and
thus, cannot comment on the risk of adverse health effects
Environmental and Molecular Mutagenesis. DOI 10.1002/em
294 Yauk et al.for the brands examined. However, it is well established
that smokers adjust their smoking behavior to compensate
for differences in nicotine content [Rickert and Robinson,
1981; Kabat, 2003; Benowitz et al., 2005; Hammond
et al., 2005].
The present data provide a proﬁle of gene expression
signatures across a range of cigarette varieties, at two
doses and time points, which can subsequently be used as
a baseline for the evaluation of new tobacco products,
including novel products that may be perceived as
reduced or modiﬁed risk tobacco products. Several regula-
tory agencies, including Health Canada and the US Food
and Drug Administration, are currently soliciting expert
input regarding the utility of various toxicity assessment
methodologies to critically evaluate cigarette manufac-
turer’s claims of reduced harm.
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